India, Sept. 6 -- India needs joint testing facilities for evaluation of extractables and leachables, material characterisation, sterilisation and filter integrity. This could include to co-fund first-qualification projects between its Indian component producers and biologics manufacturers, which would involve financing for validation runs, documentation, and comparability activities while allowing industry to retain responsibility for quality and implementation. This will turn a laboratory component into a legitimate supply source. This can be backed by incentives that favour reliability and not simply localisation. They can include factors such as traceability, an auditable quality system, on-time deliveries, technical applications supp...